• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非美国数据库的回顾性经济与结果分析:综述

Retrospective economic and outcomes analyses using non-US databases: a review.

作者信息

Shi Lizheng, Wu Eric Q, Hodges Meredith, Yu Andrew, Birnbaum Howard

机构信息

Department of Health Systems Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana 70112, USA.

出版信息

Pharmacoeconomics. 2007;25(7):563-76. doi: 10.2165/00019053-200725070-00003.

DOI:10.2165/00019053-200725070-00003
PMID:17610337
Abstract

Retrospective database analyses pose a series of methodological challenges, some of which are unique to their data sources, particularly in countries outside the US. This study aimed to qualitatively review the methodological challenges of using non-US databases to conduct retrospective economic and outcomes research studies. We conducted a MEDLINE search to obtain a sample of literature published after the year 2000 on retrospective analyses using non-US databases. We reviewed all relevant components of the selected articles in accordance with the checklist proposed for retrospective database studies by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force and identified issues found in the data sources, methods, study designs, statistics and sources of possible threats to internal and external validity. We found a wide variation in the quality of studies in terms of outcome definitions, patient selection criteria, data collection methods, sample sizes, risk adjustment methods, potential measurement errors and external validity of the studies. Few economic studies included information on indirect cost components because of a lack of relevant data. The quality of non-US retrospective database analyses varied. Future such analyses may be improved if researchers implement the checklist developed by the ISPOR Task Force on Retrospective Database Studies.

摘要

回顾性数据库分析带来了一系列方法学挑战,其中一些挑战是其数据源所特有的,尤其是在美国以外的国家。本研究旨在定性评估使用非美国数据库进行回顾性经济和结果研究的方法学挑战。我们进行了MEDLINE检索,以获取2000年后发表的关于使用非美国数据库进行回顾性分析的文献样本。我们根据国际药物经济学和结果研究协会(ISPOR)特别工作组为回顾性数据库研究提出的清单,对所选文章的所有相关部分进行了审查,并确定了在数据源、方法、研究设计、统计学以及对内部和外部有效性可能构成威胁的来源中发现的问题。我们发现,在结果定义、患者选择标准、数据收集方法、样本量、风险调整方法、潜在测量误差和研究的外部有效性方面,研究质量存在很大差异。由于缺乏相关数据,很少有经济研究纳入间接成本组成部分的信息。非美国回顾性数据库分析的质量参差不齐。如果研究人员实施ISPOR回顾性数据库研究特别工作组制定的清单,未来此类分析可能会得到改进。

相似文献

1
Retrospective economic and outcomes analyses using non-US databases: a review.使用非美国数据库的回顾性经济与结果分析:综述
Pharmacoeconomics. 2007;25(7):563-76. doi: 10.2165/00019053-200725070-00003.
2
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.ISPOR 成本效益研究质量改进良好实践工作组报告。
Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.
3
Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.比较疗效研究的良好研究实践:利用二次数据源设计非随机治疗效果研究中减轻偏倚和混杂的方法:国际药物经济学和结果研究学会回顾性数据库分析良好研究实践工作组报告--第二部分。
Value Health. 2009 Nov-Dec;12(8):1053-61. doi: 10.1111/j.1524-4733.2009.00601.x. Epub 2009 Sep 10.
4
A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases.回顾性数据库研究清单——国际药效经济学和结果研究协会(ISPOR)回顾性数据库特别工作组报告
Value Health. 2003 Mar-Apr;6(2):90-7. doi: 10.1046/j.1524-4733.2003.00242.x.
5
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.与临床试验同时进行成本效益分析的良好研究实践:药物经济学与结果研究协会随机对照试验-成本效益分析特别工作组报告
Value Health. 2005 Sep-Oct;8(5):521-33. doi: 10.1111/j.1524-4733.2005.00045.x.
6
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.比较实效研究的良好研究实践:利用二次数据源提高非随机治疗效果研究中因果推断的分析方法:ISPOR 回顾性数据库分析良好研究实践工作组报告--第三部分。
Value Health. 2009 Nov-Dec;12(8):1062-73. doi: 10.1111/j.1524-4733.2009.00602.x. Epub 2009 Sep 29.
7
Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.比较有效性研究的良好研究实践:使用二次数据源定义、报告和解释治疗效果的非随机研究:ISPOR 回顾性数据库分析良好研究实践工作组报告--第一部分。
Value Health. 2009 Nov-Dec;12(8):1044-52. doi: 10.1111/j.1524-4733.2009.00600.x. Epub 2009 Sep 29.
8
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.利用真实世界数据进行覆盖范围和支付决策:药物经济学与结果研究国际协会(ISPOR)真实世界数据特别工作组报告
Value Health. 2007 Sep-Oct;10(5):326-35. doi: 10.1111/j.1524-4733.2007.00186.x.
9
Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.安抚奶嘴的使用与母乳喂养、婴儿猝死综合征、感染和牙齿咬合不正的关系。
Int J Evid Based Healthc. 2005 Jul;3(6):147-67. doi: 10.1111/j.1479-6988.2005.00024.x.
10
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.从社会角度评估药物成本效益分析中药物成本的良好研究实践:ISPOR 药物成本工作组报告——第二部分。
Value Health. 2010 Jan-Feb;13(1):8-13. doi: 10.1111/j.1524-4733.2009.00660.x. Epub 2009 Oct 23.

引用本文的文献

1
Substance use history in behavioral-variant frontotemporal dementia versus primary progressive aphasia.行为变异型额颞叶痴呆与原发性进行性失语的物质使用史
J Addict Dis. 2016;35(1):36-41. doi: 10.1080/10550887.2015.1102026. Epub 2015 Oct 20.
2
APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.载脂蛋白 E e4 基因型与认知正常和轻度认知障碍成年人的吸烟行为:一项全国性数据集的回顾性基线分析。
Am J Drug Alcohol Abuse. 2013 Jul;39(4):219-26. doi: 10.3109/00952990.2013.800084. Epub 2013 Jun 28.

本文引用的文献

1
The nature and correlates of unmet health care needs in Ontario, Canada.加拿大安大略省未满足的医疗保健需求的性质及相关因素。
Soc Sci Med. 2006 May;62(9):2291-300. doi: 10.1016/j.socscimed.2005.10.014. Epub 2006 Jan 23.
2
Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study.术前延迟对魁北克接受膀胱切除术的膀胱癌患者生存率的影响:一项基于人群的研究。
J Urol. 2006 Jan;175(1):78-83; discussion 83. doi: 10.1016/S0022-5347(05)00070-4.
3
Comorbidity of major depression with substance use disorders.
重度抑郁症与物质使用障碍的共病情况。
Can J Psychiatry. 2005 Sep;50(10):660-6. doi: 10.1177/070674370505001013.
4
Help-seeking behaviours of individuals with mood disorders.情绪障碍患者的求助行为。
Can J Psychiatry. 2005 Sep;50(10):652-9. doi: 10.1177/070674370505001012.
5
Correlates of depressive and anxiety disorders among young Canadians.加拿大年轻人中抑郁和焦虑症的相关因素。
Can J Psychiatry. 2005 Sep;50(10):620-8. doi: 10.1177/070674370505001008.
6
Service use for mental health reasons: cross-provincial differences in rates, determinants, and equity of access.因心理健康问题而使用服务的情况:跨省在使用率、决定因素及获得服务的公平性方面的差异。
Can J Psychiatry. 2005 Sep;50(10):614-9. doi: 10.1177/070674370505001007.
7
Psychotropic medication use in Canada.加拿大的精神药物使用情况。
Can J Psychiatry. 2005 Sep;50(10):605-13. doi: 10.1177/070674370505001006.
8
Area variations in the prevalence of substance use and gambling behaviours and problems in Quebec: a multilevel analysis.魁北克物质使用、赌博行为及问题患病率的地区差异:一项多层次分析。
Can J Psychiatry. 2005 Sep;50(10):591-8. doi: 10.1177/070674370505001004.
9
Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.魁北克非甾体抗炎药的使用情况:遵循加拿大处方指南共识
Can J Clin Pharmacol. 2005 Summer;12(2):e201-11. Epub 2005 Jun 17.
10
Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec.老年人脆性骨折后的骨密度测量与骨质疏松症治疗:魁北克地区的差异及使用情况的决定因素
BMC Musculoskelet Disord. 2005 Jun 21;6:33. doi: 10.1186/1471-2474-6-33.